ABSTRACT
A comparative study of the effect of rectal administration of metronidazole on radiosensitivity of cervical cancer with relation to tumor sizes and a Hb level was conducted. The effect of a direct tumor reaction on survival was investigated. Rectal administration of metronidazole proved to be effective in large tumor sizes and a low Hb level. The use of metronidazole resulted in an increase in the number of patients with complete tumor regression and an increase in their survival. A low Hb level is an independent prognostic factor in radiation therapy of cervical cancer leading to an increase in tumor radiosensitivity.
Subject(s)
Metronidazole/therapeutic use , Radiation-Sensitizing Agents/therapeutic use , Uterine Cervical Neoplasms/radiotherapy , Administration, Rectal , Combined Modality Therapy , Female , Hemoglobins/analysis , Hemoglobins/physiology , Humans , Metronidazole/administration & dosage , Radiation-Sensitizing Agents/administration & dosage , Uterine Cervical Neoplasms/blood , Uterine Cervical Neoplasms/drug therapyABSTRACT
The paper is concerned with analysis of the results of radiation therapy of cervical cancer and intratumoral administration of metronidazole (124 patients with tumors, Stage IIB and III). At the end of the treatment, complete tumor regression in the intervention group (with metronidazole) was noted in 91% (irrespective of a stage of disease), in the control group (without metronidazole)--in 51% of the patients.